Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antimalarial drug policy: making systematic change.

× No keyword cloud information.

8 in total

Review 1. Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy.

Authors: Peter Winstanley; Stephen Ward; Robert Snow; Alasdair Breckenridge
Journal: Clin Microbiol Rev Date: 2004-07 Impact factor: 26.132

2. Amodiaquine, its desethylated metabolite, or both, inhibit the metabolism of debrisoquine (CYP2D6) and losartan (CYP2C9) in vivo.

Authors: Agneta Wennerholm; Anna Nordmark; Maria Pihlsgård; Margarita Mahindi; Leif Bertilsson; Lars L Gustafsson
Journal: Eur J Clin Pharmacol Date: 2006-06-17 Impact factor: 2.953

3. Altering Antimalarial Drug Regimens May Dramatically Enhance and Restore Drug Effectiveness.

Authors: Katherine Kay; Eva Maria Hodel; Ian M Hastings
Journal: Antimicrob Agents Chemother Date: 2015-08-03 Impact factor: 5.191

4. Intermittent preventive treatment of malaria during pregnancy: a qualitative study of knowledge, attitudes and practices of district health managers, antenatal care staff and pregnant women in Korogwe District, North-Eastern Tanzania.

Authors: Godfrey Mubyazi; Paul Bloch; Mathias Kamugisha; Andrew Kitua; Jasper Ijumba
Journal: Malar J Date: 2005-07-20 Impact factor: 2.979

5. Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug.

Authors: Godfrey M Mubyazi; Miguel A Gonzalez-Block
Journal: Malar J Date: 2005-10-20 Impact factor: 2.979

Review 6. Monitoring of efficacy and safety of artemisinin-based anti-malarials for treatment of uncomplicated malaria: a review of evidence of implementation of anti-malarial therapeutic efficacy trials in Tanzania.

Authors: Alex Shayo; Joram Buza; Deus S Ishengoma
Journal: Malar J Date: 2015-03-29 Impact factor: 2.979

7. Improving the role and contribution of pharmacokinetic analyses in antimalarial drug clinical trials.

Authors: Katherine Kay; Eva Maria Hodel; Ian M Hastings
Journal: Antimicrob Agents Chemother Date: 2014-06-30 Impact factor: 5.191

8. Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling.

Authors: Eva Maria Hodel; Katherine Kay; Daniel J Hayes; Dianne J Terlouw; Ian M Hastings
Journal: Malar J Date: 2014-04-07 Impact factor: 2.979

8 in total